Search Results - "Soliman, Mahmoud E"

Refine Results
  1. 1

    Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration by Oduro-Kwateng, Ernest, Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-06-2024)
    “…Human plasma kallikrein (PKa) is a member of the serine protease family and serves as a key mediator of the kallikrein-kinin system (KKS), which is known for…”
    Get full text
    Journal Article
  2. 2

    Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective by Aljoundi, Aimen, Bjij, Imane, El Rashedy, Ahmed, Soliman, Mahmoud E. S.

    Published in The Protein Journal (01-04-2020)
    “…The pace and efficiency of drug target strategies have been emanating debates among researchers in the field of drug development. Covalent inhibitors possess…”
    Get full text
    Journal Article
  3. 3

    Structural Insights into the Role of Pseudouridimycin Binding in Disruption of Bacterial RNA Polymerase Bridge Helix Conformational Arrangement by H Rabbad, Ali, Agoni, Clement, E Soliman, Mahmoud

    Published in Current pharmaceutical biotechnology (01-01-2023)
    “…The bridge helix (BH) is a crucial region in bacterial RNA polymerase (RNAP) catalysis. It plays an essential role in the nucleotide addition cycle (NAC) by…”
    Get more information
    Journal Article
  4. 4

    Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design by Ndagi, Umar, Falaki, Abubakar A, Abdullahi, Maryam, Lawal, Monsurat M, Soliman, Mahmoud E

    Published in RSC advances (14-05-2020)
    “…The use of antibiotics to manage infectious diseases dates back to ancient civilization, but the lack of a clear distinction between the therapeutic and toxic…”
    Get full text
    Journal Article
  5. 5

    Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity by Honarparvar, Bahareh, Govender, Thavendran, Maguire, Glenn E. M, Soliman, Mahmoud E. S, Kruger, Hendrik G

    Published in Chemical reviews (08-01-2014)
    “…An integrated approach to designing structure-based enzymatic drugs is detailed, focusing on molecular modeling, experimental bioactivity and biophysical…”
    Get full text
    Journal Article
  6. 6

    An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline? by Olotu, Fisayo, Agoni, Clement, Soremekun, Opeyemi, Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-09-2020)
    “…The pharmacological propensities of curcumin have been reported in a plethora of pre-clinical and clinical studies. However, innate attributes account for…”
    Get full text
    Journal Article
  7. 7

    Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer Therapy by Peters, Xylia Q., Agoni, Clement, Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-09-2022)
    “…Tankyrase (TNKS) belonging to the poly(ADPribose) polymerase family, are known for their multi-functioning capabilities, and play an essential role in the Wnt…”
    Get full text
    Journal Article
  8. 8

    Multi-catalytic Sites Inhibition of Bcl2 Induces Expanding of Hydrophobic Groove: A New Avenue Towards Waldenström Macroglobulinemia Therapy by Elamin, Ghazi, Aljoundi, Aimen, Soliman, Mahmoud E. S.

    Published in The Protein Journal (01-04-2022)
    “…B-cell lymphoma 2 (Bcl2) is a key protein regulator of apoptosis. The hydrophobic groove in Bcl2 is a unique structural feature to this class of enzymes and…”
    Get full text
    Journal Article
  9. 9

    Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review by Kumi, Ransford Oduro, Oti, Belinda, Abo-Dya, Nader E, Alahmdi, Mohamed Issa, Soliman, Mahmoud E S

    Published in Molecules (Basel, Switzerland) (16-11-2022)
    “…The past decade has seen most antimalarial drugs lose their clinical potency stemming from parasite resistance. Despite immense efforts by researchers to…”
    Get full text
    Journal Article
  10. 10

    Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition by Shunmugam, Letitia, Soliman, Mahmoud E. S

    Published in RSC advances (18-12-2018)
    “…Background : Concerns have been raised over the emerging pandemic status of hepatitis C virus (HCV). Current available drugs lack specificity, stability and…”
    Get full text
    Journal Article
  11. 11

    Probing the Highly Disparate Dual Inhibitory Mechanisms of Novel Quinazoline Derivatives against Mycobacterium tuberculosis Protein Kinases A and B by Olotu, Fisayo A, Soliman, Mahmoud E

    Published in Molecules (Basel, Switzerland) (16-09-2020)
    “…( ) serine/threonine (Ser/Thr) Protein kinases A (PknA) and B (PknB) have been identified as highly attractive targets for overcoming drug resistant…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Talazoparib Dual-targeting on Poly (ADP-ribose) Polymerase-1 and -16 Enzymes Offers a Promising Therapeutic Strategy in Small Cell Lung Cancer Therapy: Insight from Biophysical Computations by Mgoboza, Chwayita, Okunlola, Felix O., Akawa, Oluwole B., Aljoundi, Aimen, Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-09-2022)
    “…In recent times, inhibition of poly (ADP-ribose) polymerase (PARP) enzymes by pharmacological drugs has attracted much attention as an anticancer therapy. As…”
    Get full text
    Journal Article
  14. 14

    Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020 by Roshdy, Eslam, Mustafa, Muhamad, Shaltout, Abd El-Rahman, Radwan, Mohamed O., Ibrahim, Mahmoud A.A., Soliman, Mahmoud E., Fujita, Mikako, Otsuka, Masami, Ali, Taha F.S.

    Published in European journal of medicinal chemistry (15-11-2021)
    “…Sirtuin 2 (SIRT2) is a member of the human sirtuins, which regulates various biological processes and is deemed as a novel biomarker for different cancers…”
    Get full text
    Journal Article
  15. 15

    Probing Alterations in MDM2 Catalytic Core Structure Effect of Garcinia Mangostana Derivatives: Insight from Molecular Dynamics Simulations by El habbash, Aisha I., Aljoundi, Aimen, Elamin, Ghazi, Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-12-2022)
    “…The MDM2–p53 protein–protein interaction is a promising model for researchers to design, study, and discover new anticancer drugs. The design of…”
    Get full text
    Journal Article
  16. 16

    Glioma-Targeted Therapeutics: Computer-Aided Drug Design Prospective by Poonan, Preantha, Agoni, Clement, Ibrahim, Mahmoud A. A., Soliman, Mahmoud E. S.

    Published in The Protein Journal (01-10-2021)
    “…Amongst the several types of brain cancers known to humankind, glioma is one of the most severe and life-threatening types of cancer, comprising 40% of all…”
    Get full text
    Journal Article
  17. 17

    Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein by Adewumi, Adeniyi T, Soremekun, Opeyemi S, Ajadi, Mary B, Soliman, Mahmoud E. S

    Published in RSC advances (19-06-2020)
    “…Drug-resistant Tuberculosis (TB) has remained the top global health challenge, with a yearly estimation of 10 million infections and 1.5 million deaths in…”
    Get full text
    Journal Article
  18. 18

    A Mechanistic Probe into the Dual Inhibition of T. cruzi Glucokinase and Hexokinase in Chagas Disease Treatment – A Stone Killing Two Birds? by Omolabi, Kehinde F., Odeniran, Paul O., Olotu, Fisayo A., S. Soliman, Mahmoud E.

    Published in Chemistry & biodiversity (01-02-2021)
    “…Glucokinase (GLK) and Hexokinase (HK) have been characterized as essential targets in Trypanosoma cruzi (Tc)‐mediated infection. A recent study reported the…”
    Get full text
    Journal Article
  19. 19

    Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex by Olotu, Fisayo A., Omolabi, Kehinde F., Soliman, Mahmoud E. S.

    Published in Cell biochemistry and biophysics (01-06-2021)
    “…The recently emerged SARS-like coronavirus (SARS-CoV-2) has continued to spread rapidly among humans with alarming upsurges in global mortality rates. A major…”
    Get full text
    Journal Article
  20. 20

    Sesamol Loaded Albumin Nanoparticles: A Boosted Protective Property in Animal Models of Oxidative Stress by Zaher, Sara, Soliman, Mahmoud E., Elsabahy, Mahmoud, Hathout, Rania M.

    Published in Pharmaceuticals (Basel, Switzerland) (10-06-2022)
    “…The current study evaluated the ability of sesamol-loaded albumin nanoparticles to impart protection against oxidative stress induced by anthracyclines in…”
    Get full text
    Journal Article